BBT Capital Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-98,000
Closed -$7.86M 98
2016
Q4
$7.86M Sell
98,000
-100,000
-51% -$7.94M 1.52% 25
2016
Q3
$15.8M Hold
198,000
3.03% 5
2016
Q2
$15.4M Buy
+198,000
New +$14.1M 2.4% 12
2015
Q4
Sell
-4,370
Closed -$276K 175
2015
Q3
$276K Sell
4,370
-5,782
-57% -$413K 0.03% 150
2015
Q2
$742K Buy
+10,152
New +$733K 0.07% 133
2015
Q1
Sell
-37,195
Closed -$2.42M 229
2014
Q4
$2.42M Sell
37,195
-24,848
-40% -$1.6M 0.2% 102
2014
Q3
$3.73M Buy
+62,043
New +$4.05M 0.2% 119
2013
Q3
Sell
-69,541
Closed -$3.58M 341
2013
Q2
$3.17M Buy
+69,541
New +$3.01M 0.17% 140

Other funds holding STJ

BBT Capital Management's STJ Position: Q1 2017 in Review

BBT Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 98,000 shares — an estimated $7.86M sold.

BBT Capital Management first reported a position in STJ in Q2 2013 and held it in 8 quarters. The position peaked at $15.8M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • BBT Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • BBT Capital Management sold 98,000 St Jude Medical shares in Q1 2017, an estimated $7.86M.
  • BBT Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 8 quarters.
  • BBT Capital Management's St Jude Medical position peaked at $15.8M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on BBT Capital Management's 13F filing for Q1 2017, filed 8 May 2017.